28 Financing Emergency Research Response During Infectious Disease Outbreaks: Lessons from the World Bank and Other International Financial Institutions

Author:

Pate Muhammad Ali,Bali Sulzhan

Abstract

AbstractRecent infectious disease outbreaks have stimulated multiple institutional and operational efforts by governments, international organizations, and the private sector to ensure the world is better prepared to respond to epidemics. One of the critical advances has been the greater engagement of international financial institutions (IFIs) in supporting preparedness for and response to emerging and re-emerging infectious diseases (EIDs) with epidemic potential. Despite progress on preparedness and response, including the launch of initiatives such as the Coalition for Epidemic Preparedness Initiatives (CEPI), the world is not well prepared for the next pandemic, and research and development (R&D) for medical countermeasures against EIDs requires more attention, coordination, and investment. IFI investments in health security have so far focused primarily on disease surveillance, laboratory capacity, outbreak readiness, and human resources for health security, under initiatives that have not so far included sufficient focus on R&D for preparedness and accelerated development of new vaccines, therapeutics, and diagnostics (VTD) against novel pathogens.This chapter examines how IFIs can better contribute to the advancement of EID preparedness and response. It describes IFI initiatives, including those by the World Bank, that complement other global efforts to galvanize emergency research during EID outbreaks. IFI initiatives seek to strengthen national and regional infectious disease response systems. Through IFI financial management expertise, leveraging IFIs’ comparative advantage in fund management services and their use of development lending, IFIs also seek to bolster core capacity at the intersection of health systems and clinical research. This chapter also notes some constraints faced by IFIs in financing clinical research and examines lessons and opportunities for IFIs to accelerate investment in emergency research.

Publisher

Springer International Publishing

Reference78 articles.

1. ACE. The ACE impact project. Accra-North: Association of African Universities; 2022. https://ace.aau.org/#:~:text=The%20Africa%20Higher%20Education%20Centers,%2C%20Agriculture%2C%20applied%20Social%20Science%20%2F. Accessed 22 Nov 2022.

2. ADB. Annual report 2021: toward a green and inclusive recovery. Manila: Asian Development Bank; 2021. Report No.: ISBN: 978-92-9269-422-7 (print); 978-92-9269-423-4 (electronic); 978-92-9269-424-1 (ebook).

3. African Development Bank. Evaluation of the Bank Group’s support to RMCs in the face of COVID-19. 2021.

4. African Risk Capacity (ARC) Group. African Risk Capacity (ARC) Group. Johannesburg: African Risk Capacity (ARC) Group; 2022. https://www.arc.int/. Accessed 17 Nov 2022.

5. Ajogbasile FV, Oguzie JU, Oluniyi PE, Eromon PE, Uwanibe JN, Mehta SB, et al. Real-time metagenomic analysis of undiagnosed fever cases unveils a yellow fever outbreak in Edo state, Nigeria. Sci Rep. 2020;10(1):1–6. https://doi.org/10.1038/s41598-020-59880-w.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3